Source: Washington Examiner
by Jeffrey Mazzella
“In 1992, Congress created what’s commonly known as the 340B program in order to help safety-net hospitals and clinics stretch limited resources to serve low-income and uninsured patients. By requiring pharmaceutical manufacturers to sell prescription drugs at steep discounts to qualifying hospitals and clinics, the logic went, the 340B program aimed to keep medications accessible and affordable in underserved communities. Nearly 35 years later, however, the program bears little resemblance to what Congress had in mind, and there’s no reliable way to know whether patients still benefit from its growth.” (07/28/26)